The creation of a Virology Core for the CFAR will provide investigators with a state-of-the-art facility that will have the capability and capacity to perform all aspects of HIV virology testing. The overall goals of the Virology Core will be to provide laboratory assistance to investigators requiring sophisticated protocols for assessing virologic endpoints to therapy, to provide expert assistance for the interpretation of results to clinicians involved in the care of patients with HIV infection, and to provide instruction and technical advice to researchers who are interested in developing sophisticated virologic procedures for their HIV projects. Specifically, the Virology Core will: (1) receive, process, and test plasma or serum, PBMC, tissues, secretions and excretions from patients with HIV; (2) isolated and propagate HIV from these samples; (3) perform HIV-specific diagnostic assays for measurement of viral or surrogate markers using biochemical, immunologic, and molecular approaches; (4) perform gene ampliation techniques to assist in the detection of HIV-specific RNA or proviral DNA from clinical specimens using polymerase chain reaction (PCR) methodology; (5) evaluate drug susceptibility of HIV isolates; and (6) serve as a repository for the long-term storage of clinical specimens from adults infected with HIV and maintain a computerized freezer storage and tracking program so that such specimens will be available for subsequent research programs.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI036211-05
Application #
6099810
Study Section
Project Start
1998-04-01
Project End
1999-08-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Tan, Qiumin; Brunetti, Lorenzo; Rousseaux, Maxime W C et al. (2018) Loss of Capicua alters early T cell development and predisposes mice to T cell lymphoblastic leukemia/lymphoma. Proc Natl Acad Sci U S A 115:E1511-E1519
Bayrer, James R; Wang, Hongtao; Nattiv, Roy et al. (2018) LRH-1 mitigates intestinal inflammatory disease by maintaining epithelial homeostasis and cell survival. Nat Commun 9:4055
Bui, Thanh Cong; Scheurer, Michael E; Pham, Vy Thi-Tuong et al. (2018) Intravaginal practices and genital human papillomavirus infection among female sex workers in Cambodia. J Med Virol 90:1765-1774
Kim, Myunghoo; Galan, Carolina; Hill, Andrea A et al. (2018) Critical Role for the Microbiota in CX3CR1+ Intestinal Mononuclear Phagocyte Regulation of Intestinal T Cell Responses. Immunity 49:151-163.e5
Martini-Stoica, Heidi; Cole, Allysa L; Swartzlander, Daniel B et al. (2018) TFEB enhances astroglial uptake of extracellular tau species and reduces tau spreading. J Exp Med 215:2355-2377
Kogiso, Mari; Qi, Lin; Braun, Frank K et al. (2018) Concurrent Inhibition of Neurosphere and Monolayer Cells of Pediatric Glioblastoma by Aurora A Inhibitor MLN8237 Predicted Survival Extension in PDOX Models. Clin Cancer Res 24:2159-2170
Xiao, Yangyan; de Paiva, Cintia S; Yu, Zhiyuan et al. (2018) Goblet cell-produced retinoic acid suppresses CD86 expression and IL-12 production in bone marrow-derived cells. Int Immunol 30:457-470
Yosef, Nejla; Vadakkan, Tegy J; Park, June-Hee et al. (2018) The phenotypic and functional properties of mouse yolk-sac-derived embryonic macrophages. Dev Biol 442:138-154
Kho, Jordan; Tian, Xiaoyu; Wong, Wing-Tak et al. (2018) Argininosuccinate Lyase Deficiency Causes an Endothelial-Dependent Form of Hypertension. Am J Hum Genet 103:276-287
Grzeskowiak, Caitlin L; Kundu, Samrat T; Mo, Xiulei et al. (2018) In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer. Nat Commun 9:2732

Showing the most recent 10 out of 690 publications